These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30246276)

  • 1. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study.
    Taniguchi F; Ota I; Iba Y; Toda T; Tagashira Y; Ohata Y; Kurioka H; Endo Y; Sunada H; Noma H; Azuma Y; Harada T
    J Obstet Gynaecol Res; 2019 Jan; 45(1):168-175. PubMed ID: 30246276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study.
    Trivedi N; Chauhan N; Vaidya V
    Gynecol Endocrinol; 2016 Aug; 32(8):667-671. PubMed ID: 26950060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study.
    Sukhikh GT; Adamyan LV; Dubrovina SO; Baranov II; Bezhenar VF; Kozachenko AV; Radzinsky VE; Orazov MR; Yarmolinskaya MI; Olofsson JI
    Fertil Steril; 2021 Dec; 116(6):1568-1577. PubMed ID: 34465452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study.
    Kitawaki J; Koga K; Kanzo T; Momoeda M
    Reprod Med Biol; 2021 Jul; 20(3):345-351. PubMed ID: 34262403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of severe primary and secondary dysmenorrhea with a retrosteroid].
    Bayer R
    Wien Med Wochenschr; 1971 Sep; 121(36):618-24. PubMed ID: 5110842
    [No Abstract]   [Full Text] [Related]  

  • 6. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study.
    Podzolkova N; Tatarchuk T; Doshchanova A; Eshimbetova G; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(3):246-9. PubMed ID: 26613278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
    Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
    Strecker JR
    Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of dydrogesterone in dysmehorrhea. Prostaglandin levels in menstrual blood].
    Zahradnik HP
    Fortschr Med; 1984 Apr; 102(15):439-42. PubMed ID: 6724478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone (Gynorest and Duphaston).
    Med Lett Drugs Ther; 1969 Apr; 11(7):31-2. PubMed ID: 5781648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of dydrogesterone in postpubertal menstruation disorders].
    Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the efficacy of dydrogesterone and calcium plus vitamin D in improving women's general health.
    Khajehei M; Abdali K; Tabatabaee HR
    Afr J Psychiatry (Johannesbg); 2010 Jul; 13(3):218-24. PubMed ID: 20957321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
    Stute P
    Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 24-h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized, double-blinded, placebo-controlled crossover study.
    Iacovides S; Baker FC; Avidon I
    Arch Gynecol Obstet; 2014 May; 289(5):993-1002. PubMed ID: 24190696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary dysmenorrhea treated with staging acupoint catgut embedment therapy: a randomized controlled trial].
    Bi Y; Shao XM; Xuan LH
    Zhongguo Zhen Jiu; 2014 Feb; 34(2):115-9. PubMed ID: 24796043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N
    Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.